Strategic MOU with Core Manufacturing Affiliate of PSE-Listed IONICS Group
Expanding Cooperation to SKD Production, Philippine Commercialization, and Joint AI R&D

IONICS EMS personnel inspecting the Otom production facility onsite

IONICS EMS personnel inspecting the Otom production facility onsite

View original image

OTOM, a company specializing in portable X-ray devices, is partnering with the leading Philippine EMS (Electronics Manufacturing Services) firm IONICS EMS to enable local business operations. As a result, the two companies will actively pursue the SKD (Semi Knocked Down) manufacturing of portable X-ray devices and joint research and development (R&D) for medical imaging AI in the Philippines.


According to OTOM, it signed a strategic memorandum of understanding (MOU) with IONICS EMS on September 2, 2026, at its headquarters and factory in Gwangju, South Korea. IONICS EMS is a core EMS manufacturing affiliate controlled by IONICS, INC., which is listed on the Philippine Stock Exchange (PSE), and provides manufacturing, engineering, product development, and mass production services for global electronics companies.


The IONICS Group, a manufacturing conglomerate, recorded sales in excess of 100 million dollars as of 2025. IONICS EMS covers the entire spectrum of electronics manufacturing, including PCBA, finished product assembly, transitioning new products to mass production (NPI), and supply chain management. Notably, the company holds ISO 13485 certification for medical device quality management systems, which proves its capabilities in manufacturing medical devices.


The core aspect of this MOU is that IONICS EMS is reviewing OTOM's portable X-ray MINE ALNU and the medical imaging AI O-View as targets for local manufacturing and joint development.


Initially, the two companies will explore the feasibility of establishing a local SKD production system for MINE ALNU in the Philippines. The plan is to integrate OTOM's core technologies and quality standards with IONICS EMS's manufacturing and engineering infrastructure to develop detailed systems for assembly, testing, and quality management.


The two companies will also consider commercialization strategies targeting medical institutions, public health facilities, and the tuberculosis (TB) screening market in the Philippines. In particular, they have designated local clinical validation of O-View, enhancement of AI performance, and adaptation of AI for the Philippine healthcare environment as major joint R&D fields.


If OTOM's portable device technology can deliver effective cost savings through the mass production infrastructure of IONICS EMS, then not only will this help the company establish a strong foothold in the Philippine market, but it is also expected to accelerate expansion across Southeast Asia (ASEAN) as a whole.


The market views this cooperation as fundamentally different from a typical overseas distribution agreement. The fact that IONICS EMS, with its actual manufacturing infrastructure and global EMS experience in the Philippines, has started to review OTOM's X-ray and medical AI technologies for production and R&D collaboration, is drawing attention to the possibility of expanded cooperation going forward.


An OTOM official stated, "This agreement is meaningful in that it lays the foundation for expanding the scope of collaboration beyond product sales to include local manufacturing and joint development of medical imaging AI. Through further working-level discussions, we plan to connect Philippine local production, regulatory approval, commercialization, and joint AI R&D into concrete business initiatives."



However, this MOU is not a final contract that sets specific production volumes or investment amounts. The two companies plan to determine the scope of SKD manufacturing, quality management, regulatory approvals, local sales, and the terms for joint AI development step by step through additional consultations.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing